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Abstract
Background: Anxiety disorders are the most prevalent mental health condition in Australia. In addition, there are
many people who experience problematic anxiety symptoms who do not receive an anxiety disorder diagnosis but
require treatment. As herbal medicine use is popular in Australia, and little is known about how adults experiencing
anxiety are using these medicines, this study aimed to identify how Australian adults who experience anxiety are
using herbal medicines.
Methods: An online cross-sectional descriptive study was conducted using purposive convenience sampling to
recruit Australian adults who have experienced anxiety symptoms and have used herbal medicines (N = 400).
Descriptive statistics, chi-square test of contingency, analysis of variance, and simple logistic regression was used to
analyse the data.
Results: Eighty two percent of participants experienced anxiety symptoms in the previous 12 months, with 47 %
reporting having previously been diagnosed with an anxiety disorder. In addition, 72.8 % had used herbal
medicines specifically for anxiety symptoms in their lifetime, while 55.3 % had used prescribed pharmaceuticals,
with 27.5 % having used herbal medicines concurrently with prescribed pharmaceuticals. The Internet and family
and friends were the most frequently used sources of information about herbal medicines. Forty eight percent of
participants did not disclose their herbal medicine use to their doctor.
Conclusions: Herbal medicines are being used by adults with anxiety and are commonly self-prescribed for anxiety
symptoms. Health practitioners who are experts in herbal medicine prescribing are consulted infrequently. In
addition, herbal medicine use is often not disclosed to health practitioners. These behaviours are concerning as
people may not be receiving the most suitable treatments, and their use of herbal medicines may even be
dangerous. It is critical we develop a better understanding of why people are using these medicines, and how we
can develop improved health literacy to help with treatment decision making to ensure people receive optimal
care.
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Background
The experience of anxiety is complex, and anxiety disor-
ders are the most prevalent mental health condition in
Australia. Over a quarter of Australian adults reported
having an anxiety disorder diagnosis in their lifetime,
and 14.4 % had a diagnosis in the previous 12 months
[1]. These figures exclude many people who experience
problematic anxiety symptoms but do not meet the diag-
nostic criteria of an anxiety disorder [2, 3], thus is likely
to underestimate prevalence. Both psychological and
pharmaceutical evidence-based treatments are used to
treat anxiety symptoms with varying levels of success.
People can have poor treatment compliance, find treat-
ments ineffective, or be concerned about the unwanted
side-effects of pharmacotherapies [4]. In addition, people
may not seek treatment through health professionals
due to fear of stigma or lack of accessibility [5]. This
may lead people to seek out alternative or complemen-
tary treatments such as herbal medicines, which are
widely available to the public and allow for self-
prescription.
Herbal medicines are a popular complementary and
alternative medicine (CAM) in Australia, with recent
prevalence in the general population estimated at 37 %
[6]. However, little is known about herbal medicine use
in adults who experience anxiety. A recent review of the
literature found that herbal medicine use for anxiety
symptoms ranged from 2 % (general population sample)
to 22 % (of those with an anxiety disorder diagnosis)
across four countries [7]. This review also found that
people with more severe anxiety (i.e. an anxiety disorder
diagnosis) were significantly more likely to use herbal
medicines compared to those with less severe anxiety
(i.e. no disorder diagnosis) [8, 9]. In addition, people
with a generalised anxiety disorder (GAD) diagnosis
(Diagnostic and Statistical Manual of Mental Disorders-
IV) used more herbal medicines compared to those with
any other anxiety disorder diagnosis [10, 11].
While herbal medicines may complement conventional
treatments, or provide an effective alternative for some
people, there are potential problems with the use of
herbal medicines. For example, there is a risk of herb-
drug interactions if taking pharmaceutical medicines
concurrently with herbal medicines [12]. There is also a
risk that those who are self-prescribing may be using in-
effective treatments, or may not be receiving the most
suitable treatments [13]. This is supported by research
revealing that people using herbal medicines do not ne-
cessarily take them consistent with their evidence-based
indications. Bardia and colleagues [14] found that only
54.9 % of herbal medicine users in the US used herbal
medicines in line with their evidence-based indications.
The authors suggest that the correct information on the
indications for herbal medicines may not be reaching
consumers. One explanation for this may be that people
are getting their herbal medicine information from non-
professional sources such as friends and family, the
Internet, or popular media. High use of non-professional
information sources for herbal medicines has been re-
ported in an Australian study of pregnant woman, with
32 % of herbal medicine users (n = 458) self-prescribing
them for anxiety symptoms [15], but it is unclear how
this relates to information sources in the general
population.
The potential risks of herbal medicine use are in-
creased if people do not disclose their herbal medicine
use to health practitioners. Non-disclosure of CAM use
was found to be as high as 37 % in Australian psychiatric
patients (N = 52) [16]. Research on a range of cohorts
has found high non-disclosure rates of CAM use to
health practitioners for fear of discrimination, or beliefs
that their CAM use is not relevant to the practitioner, or
that the practitioner did not ask about their CAM use
[17]. The non-disclosure rates of herbal medicine use in
adults experiencing anxiety is yet to be reported.
As there is no research to date that has reported the
herbal medicine use behaviour of adults experiencing
anxiety, the overall aim of this study was to identify how
Australian adults who experience anxiety are using
herbal medicines. As people with an anxiety disorder
diagnosis have been found to have greater use of herbal
medicines than those without a diagnosis [8], we
hypothesised:
1. Having an anxiety disorder diagnosis would predict a
greater probability of herbal medicine use for
anxiety symptoms in the previous 12 months
compared to those without a disorder diagnosis
2. Having more severe anxiety symptoms in the
previous week would predict greater current herbal




Purposive criterion sampling was used to recruit Australian
adults (18 years and over) who have used herbal medicines,
and have experienced anxiety symptoms in their lifetime.
Anxiety symptoms were described to participants as sweat-
ing, palpitations, nervousness, trembling, muscular tension,
restlessness, feeling easily fatigued, irritability, over reaction
to surprises, difficulty concentrating, irrational fears, worry,
and sleep disturbances. Herbal medicines were defined as
medicines made from whole plant parts in the form of tab-
lets, capsules, liquid extracts, teas, decoctions, creams and
ointments.
Survey invitations were emailed to 10,575 members of
an existing database representative of the general
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Australian population. The database consisted of people
who had registered their interest in participating in re-
search. Eight hundred and ninety six people responded
to the invitation—a response rate of 8.47 %. Of the 896
respondents 62.2 % (n = 544) had used herbal medicines,
and 79.6 % (n = 710) had experienced anxiety symptoms.
Four hundred people met the criteria for the study (i.e.
used herbal medicines and had experienced anxiety).
Procedure
Ethics approval was provided by Charles Sturt University
(2014/033) in accordance with the declaration of
Helsinki.
Once participants responded to the emailed invitation
they were directed to a GroupQuality® online survey tool
where participants could complete the survey. An infor-
mation page was presented to participants that asked for
informed consent. Continuing to complete the survey
was considered consent. They were then required to an-
swer yes or no to three screening questions: 1) Are you
18 years of age or older?; 2) To the best of your know-
ledge, have you ever experienced anxiety?; and 3) Have
you ever used herbal medicines? If answering no to any
of these questions they did not meet the criteria, were
thanked for their time, and could not continue with the
survey. The survey took approximately 30 min to
complete. Participants were paid a nominal amount for
their participation based on time taken to complete ($10
for 30 min).
Measures
Demographic and medicine use questionnaire
A questionnaire was used that included the demographic
items: age, gender, postcode, and education level; and
items measuring herbal and pharmaceutical medicine
use, communication with health care providers, informa-
tion sources use and disclosure of herbal medicine use.
Health practitioner and herbal medicine use questions
Participants were asked which health providers they had
seen in the previous 12 months from a list of practi-
tioners who were considered most likely to prescribe
herbal medicines; they also had the opportunity to indi-
cate “other” if there were practitioners they had seen
that were not on the list. Both the practitioner use ques-
tions and the herbal medicine use questions were
adapted from the International Complementary and Al-
ternative Medicine Questionnaire [18], which measures
CAM use. The changes made to the questionnaire were
related to formatting to enable improved online delivery,
and to focus specifically on herbal medicines rather than
CAM in general. The question Have you used any of
these herbs in the last 12 months? was presented to par-
ticipants with the option of choosing from a list of 17
herbs commonly used to treat anxiety, plus the option of
choosing “herbal formula” or “other herbs used”. For
each herb selected a series of questions were asked relat-
ing to how the medicines were used, which included
current use of each herb selected. A variable for current
herbal medicine use was created, with 2 = Yes if partici-
pants indicated they currently used at least one herbal
medicine for anxiety, and 1 =No if they did not currently
use a herbal medicine for anxiety. The item During the
last 12 months I have used herbal medicines to treat
anxiety symptoms was measured using a Likert type
scale ranging from 1 = False and 7 = True.
Anxiety disorder diagnosis
A dichotomous (Yes, No) item was used to measure self-
reported anxiety disorder diagnosis: Have you ever been
diagnosed with an anxiety disorder?
The state-trait anxiety inventory (STAI)
The STAI was used to measure both state and trait anx-
iety. This scale has been widely used, and has demon-
strated good reliability and validity in both general and
clinical populations (STAI-State alpha = .94, STAI-Trait
alpha = .94) [19].
The depression anxiety and stress scale short version
(DASS-21)
The DASS-21 was used as a secondary measure of anxiety,
and to identify those with stress and depression symptoms
[20] as it is a widely used clinical screening tool for these
constructs and has good reliability (alpha = .89 stress, .90
depression, .79 anxiety) and validity [19].
Statistical analysis
The data were analysed using SPSS Statistics Version 22.
The data were checked for missing values, and items
recoded as required. Only one missing value was found
for age. Listwise exclusion of the missing value was
performed. Statistical assumptions were checked for all
relevant analyses, including skewness and kurtosis of vari-
ables. Normal distributions were checked using histo-
grams, and boxplots used to check for univariate outliers.
All assumptions were found to be within acceptable range.
Descriptive statistics were used to report means, fre-
quencies, and percentages. Chi-square test for goodness
of fit was used to determine differences in the frequency
of herbal medicine use for anxiety symptoms between
those with and without an anxiety disorder diagnosis.
As we found a high amount of non-disclosure of herbal
medicine use in our sample, we sought to determine
whether there was a relationship between nondisclosure
and the following variables: anxiety disorder diagnosis,
anxiety symptoms in the previous 12 months, having used
herbal medicines for anxiety symptoms, having used
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pharmaceuticals for anxiety symptoms, and having used a
combination of herbal medicines and pharmaceuticals for
anxiety symptoms. Chi-square test of contingency was
used to test relations between dichotomous variables, and
Cramer’s V was used to report effect size [21].
A two-way analysis of variance (ANOVA) was used to
examine the effects of anxiety disorder diagnosis and
having anxiety symptoms in the previous 12 months on
herbal medicine use in the previous 12 months. In
addition, simple logistic regression was performed to de-
termine whether anxiety symptoms in the previous week
predicted current herbal medicine use for anxiety symp-
toms (a dichotomous variable).
Results
Participant demographics
Of the 400 participants there were 203 males (50.8 %)
and 197 females (49.3 %). The mean age was 49.1 (SD =
15.53), with ages ranging from 18 to 85. The majority of
participants resided in the state of New South Wales
(NSW) (34 %), while the least represented state was the
Northern Territory (NT) (n = 1). The highest level of
education for the majority of participants was Bachelor
Degree (22.8 %), with the least amount of participants
either having a Year 10 or equivalent (12 %) or a Post-
graduate qualification (12 %) as their highest level of
education. Participants’ demographics are summarised
in Table 1.
Scale reliabilities and mental health characteristics of
participants
The reliabilities for each of the DASS-21 and the STAI
scales in the current study were excellent, and within
the range of previous research using similar cohorts.
The Cronbach alpha levels are displayed in Table 1 with
means and standard deviations, along with reference to
previous studies using general population and similar
clinical samples. The mean scores for the DASS-21
scales indicate that this cohort has worse mental health
compared to general population norms, with stress clas-
sified as mild, and depression and anxiety as moderate
[22]. The mean scores for the STAI State and Trait
scales were between general population and clinical
norms, as shown in Table 2.
Anxiety and medicine use characteristics
The majority of participants (82.3 %) experienced anx-
iety symptoms in the previous 12 months, with 47 %
reporting having previously been diagnosed with an anx-
iety disorder (type of disorder not specified). In addition,
72.8 % of participants used herbal medicines specifically
for anxiety symptoms in their lifetime, while 55.3 % had
used prescribed pharmaceuticals, with 27.5 % having
used herbal medicines concurrently with prescribed
pharmaceuticals. Of those with an anxiety disorder diag-
nosis (n = 188), 83.5 % used herbal medicines for anxiety
symptoms, which compared to 63.2 % of those without a
disorder diagnosis (n = 134). Chi-square test for good-
ness of fit indicated that those with an anxiety disorder
diagnosis reported a significantly greater frequency of
herbal medicine use for anxiety symptoms than those
without a diagnosis, χ2 (1, N = 188) = 84.45, p = .000.
Cohen’s w was 0.67, which is a large effect size [21].
Practitioner use and herbal medicine prescribing
General practitioners were the most frequently con-
sulted health practitioner, with 87 % of people having
seen a medical doctor in the last 12 months, with an
average of 12 visits over this time. In contrast, Western
herbalists (4.8 %) and homeopaths (4.5 %) were the
Table 1 Participants’ demographics including: age, gender,
state of residence, and education level





















Year 10 or equivalent 12 (48)
Year 12 or equivalent 15.8 (63)
Trade certificate 16 (64)
Diploma or Advanced diploma 21.5 (86)
Bachelor degree 22.8 (91)
Postgraduate qualification 12 (48)
Note. There was missing data for one participant on the variable age and
state/territory. ACT Australian Capital Territory, NSW New South Wales, NT
Northern Territory, QLD Queensland, SA South Australia, TAS Tasmania, VIC
Victoria, WA Western Australia
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practitioners seen by the least number of participants.
However, while it was not common for people to consult
Western herbalists, those who did had an average of 7.5
visits in the previous 12 months, which was the second
highest number of consultations for a practitioner dur-
ing that time. The second most consulted practitioners
in the previous 12 months were psychologists (19.5 %),
who were seen an average of 6.2 times. All health practi-
tioners were reported to have prescribed herbal medi-
cines to varying degrees, with the most frequent being
traditional Chinese medicine (TCM) practitioners
(83.3 %), Western herbalists (73.7 %), and naturopaths
(77 %). This compared to the lowest prescribers of
herbal medicines, who were psychiatrists (9.1 %), psy-
chologists (7.7 %), and general practitioners (5.5 %).
Health practitioner use and herbal medicine prescription
is summarised in Table 3.
Herbal medicine use
The most commonly used herbal medicine to treat
anxiety symptoms in the previous 12 months was
chamomile (43 %), followed by lavender (32.5 %). For
all herbs used self-prescription was common, and
ranged from 8.7 % (gotu kola) to 68 % (chamomile) for
individual herbs. Ginkgo was reported to be the most
frequently prescribed herb (31.3 %) to treat anxiety
symptoms by a herbal medicine practitioner, with oats
being the least prescribed by these practitioners (5.1 %).
The least used herbs for anxiety symptoms in the previ-
ous 12 months were zizyphus (1.5 %), bacopa (2 %),
and skullcap (2 %). See Table 4 for the frequency of
herbal medicines used for anxiety symptoms, and how
they were prescribed. Chamomile was most frequently
ingested as a tea (89.7 %), with liquorice most fre-
quently used as a powder (59.1 %), valerian most fre-
quently used as a tablet (70.5 %), and lavender most
frequently used as a liquid extract (34.3 %). All herbal
medicines were used in a range of different prepara-
tions (see Table 5).
Table 2 Scale reliabilities of the DASS-21 and STAI
Current study General population normsa Clinical population
Scale M SD α M SD α M SD α
DASS-21 Stress 8.07 5.28 .91 3.99 4.24 .89 21.10b 11.15b .93b
DASS-21 Depression 6.98 5.87 .94 2.57 3.86 .90 10.65b 9.30b .96b
DASS Anxiety 5.82 5.14 .90 1.74 2.78 .79 10.90b 8.12b .89b
STAI Trait 46.63 12.39 .94 36.35 11.39 .94 55c 10c _d
STAI State 43.65 12.87 .94 33.16 11.69 .94 52c 13c _ d
Note. α Cronbach alpha, DASS Depression Anxiety Stress Scale, STAI State Trait Anxiety Inventory
a Australian general population norms taken from [19]
b Clinical population norms (anxiety or mood disorder diagnosis) for the DASS-21 taken from [21]
c Clinical population norms (GAD diagnosis) for the STAI State and Trait scales taken from [22]
d Not reported
















% (n) M b % (n)c
General
practitioner
87 (348) 12.04 5.5 (19)
Psychologist 19.5 (78) 6.20 7.7 (6)
Chiropractor 15 (60) 6.62 15 (9)
Acupuncturist 13 (52) 6.73 42.3 (22)
Naturopath 12 (48) 2.76 77.1 (37)
TCM
practitioner
12 (48) 4.83 83.3 (40)
Nutritionist 10.3 (41) 3.07 19.5 (8)
Psychiatrist 8.3 (33) 4.88 9.1 (3)
Western
herbalist
4.8 (19) 7.56 73.7 (14)
Homeopath 4.5 (18) 4.00 72.2 (13)











Note. TCM Traditional Chinese medicine practitioner. CAM Complementary and
alternative medicine
aA multiple response item; participants were asked to select from a
predetermined list of health practitioners or other where they could list the
other type of practitioner seen
bMean number of visits to practitioner in previous 12 months
cFrequency and percentage of number of each practitioner seen in the
previous 12 months
dOther CAM practitioners included iridologist, reflexologist; and Japanese,
Korean, and Indonesian herbalists as described by participants
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Information sources
The Internet (53 %) was the most frequently used source
of information for herbal medicines, with media adver-
tisements being used the least (5.5 %). Use of informa-
tion sources is displayed in Table 6.
Disclosure of herbal medicine use
Forty eight percent of participants did not disclose their
herbal medicine use to their doctor, with 55.3 % not dis-
closing to other health care providers.
Disclosure of herbal medicine use to both medical
doctors and other health practitioners had small signifi-
cant relations with the following variables: having had an
anxiety disorder diagnosis, having used herbal medicines
for anxiety symptoms, having used pharmaceutical medi-
cines for anxiety symptoms, and having used a combin-
ation of pharmaceutical and herbal medicines for anxiety
symptoms. The effect size of all these relations was small
according to Cramer’s V [21]. These results mean that
people who had an anxiety disorder diagnosis, or used
either herbal medicines or pharmaceuticals for anxiety




12 months (N = 400)
Current
usea
Who prescribed % (n)











Bacopa 2 (8) 62.5 (5) 35.7 (5) 7.1 (1) 7.1 (1) 0 (0) 0 (0) 0 (0) 50 (7)
Chamomile 43 (172) 65.1
(112)
68 (119) 15.4 (27) 1.7 (3) 4 (7) 2.9 (5) 3.4 (6) 4.6
(8)
Ginkgo 13.8 (55) 47.3 (26) 42.2 (27) 31.3 (20) 3.1 (2) 3.1 (2) 0 (0) 3.1 (2) 17.2
(11)
Ginsengb 19.5 (78) 50 (39) 37.1 (33) 28.1 (25) 3.4 (3) 5.6 (5) 3.4 (3) 3.4 (3) 19.1
(17)
Gotu kola 1.5 (6) 83.3 (5) 8.7 (2) 17.4 (4) 0 (0) 0 (0) 0 (0) 0 (0) 73.9
(17)
Kava 3.5 (14) 42.9 (6) 16.7 (5) 20 (6) 6.7 (2) 0 (0) 0 (0) 0 (0) 56.7
(17)
Lavender 32.5 (130) 60.8 (79) 58.6 (82) 12.9 (18) 5 (7) 4.3 (6) 1.4 (2) 2.1 (3) 15.7
(22)
Lemon balm 8.3 (33) 57.6 (19) 32.7 (16) 22.4 (11) 2 (1) 0 (0) 0 (0) 4.1 (2) 38.8
(19)
Liquorice 11 (44) 43.2 (19) 50.8 (30) 6.8 (4) 3.4 (2) 5.1 (3) 5.1 (3) 1.7 (1) 27.1
(16)
Oats 15.5 (62) 59.7 (37) 55.1 (43) 5.1 (4) 5.1 (4) 7.7 (6) 0 (0) 3.8 (3) 23.1
(18)
Passionflower 7 (28) 60.7 (17) 29.4 (15) 15.7 (8) 7.8 (4) 2 (1) 0 (0) 0 (0) 45.1
(23)
Rhodiola 3 (12) 58.3 (7) 10.8 (4) 16.2 (6) 2.7 (1) 0 (0) 0 (0) 2.7 (1) 67.6
(25)




19.3 (77) 39 (30) 36 (36) 23 (23) 4 (4) 6 (6) 6 (6) 2 (2) 23
(23)
Valerian 20.8 (83) 45.8 (38) 45.7 (48) 13.3 (14) 7.6 (8) 5.7 (6) 1.9 (2) 1.9 (2) 23.8
(25)
Withania 2.5 (10) 60 (6) 11.4 (4) 11.4 (4) 0 (0) 2.9 (1) 0 (0) 2.9 (1) 71.4
(25)
Zizyphus 1.5 (6) 83.3 (5) 9.7 (3) 9.7 (3) 0 (0) 0 (0) 0 (0) 0 (0) 80.6
(25)
Other 19.8 (79) 40 (32) 26.9 (28) 8.7 (9) 9.6 (10) 3.8 (4) 0 (0) 3.8 (4) 47.1
(49)
aReported as percentage of users of each herb in the previous 12 months
b Either Koren or Siberian ginseng
c Herbal medicine practitioner included naturopaths, Western herbalists, traditional Chinese medicine practitioners, and acupuncturists
dOther CAM = includes chiropractors, nutritionists, and homeopaths
eOther general = any other health practitioner not listed
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symptoms, were significantly more likely to disclose
their herbal medicine use to their doctor and other
health practitioners. However, those who used a combin-
ation of herbal and pharmaceutical medicines for anxiety
symptoms were significantly less likely to disclose their
use. There was no relation found between disclosure of
herbal medicine use and having anxiety symptoms in the
previous 12 months. Statistics and results for the chi-
square tests of contingency are presented in Table 7.
Anxiety severity and herbal medicine use for anxiety
symptoms
We further investigated the characteristics of those who
used herbal medicines for anxiety symptoms. First, we
were interested in whether having anxiety symptoms in
the previous 12 months or an anxiety disorder diagnosis,
influenced the probability of herbal medicine use in the
previous 12 months. Second, we wanted to know if anx-
iety symptom severity in the previous week predicted
current herbal medicine use for anxiety symptoms.
A two-way analysis of variance (ANOVA) was used to
examine the effects of anxiety disorder diagnosis and
having anxiety symptoms in the previous 12 months on
herbal medicine use in the previous 12 months. There
was homogeneity of variances as assessed by Levene’s
test, p = .45. People with a previous anxiety disorder
diagnosis (M = 4.90, SE = 0.25, 95 % CI [4.40, 5.40]) were
more likely to use herbal medicines in the previous
12 months than those without an anxiety disorder diag-
nosis (M = 4.04, SE = 0.18, 95 % CI [3.70, 4.39]). Anxiety
disorder diagnosis accounted for 2 % of the variability of
herbal medicine use in the previous 12 months, which is
a small effect size (partial η2 = .02). Anxiety symptoms in
the previous 12 months accounted for 2 % of the vari-
ability in herbal medicine use for anxiety symptoms in
the previous 12 months, partial η2 = .02 (see Table 8).
People with anxiety symptoms in the previous
12 months (M = 4.95, SE = 0.12, 95 % CI [4.71, 5.19])
Table 5 Percentage of users for each herbal medicine preparation
Herbal medicine Herbal medicine preparation type % (n)a
Tea Powder Tablet Liquid extract In a formula Other
Bacopa 21.4 (3) 0 (0) 14.3 (2) 14.3 (2) 50 (4) 50 (7)
Chamomile 89.7 (157) 1.7 (3) 3.4 (6) 3.4 (6) 25.6 (44) 1.7 (3)
Ginkgo 32.8 (21) 7.8 (5) 37.5 (24) 7.8 (5) 56.4 (31) 14.1 (9)
Ginseng (Korean or Siberian) 30.3 (27) 7.9 (7) 33.7 (30) 13.5 (12) 43.6 (34) 14.6 (13)
Gotu kola 8.7 (2) 4.3 (1) 4.3 (1) 4.3 (1) 66.7 (4) 78.3 (18)
Kava 16.7 (5) 6.7 (2) 16.7 (5) 3.3 (1) 35.7 (5) 56.7 (17)
Lavender 20 (28) 7.9 (11) 3.6 (5) 34.3 (48) 23.8 (31) 34.3 (48)
Lemon balm 44.9 (22) 6.1 (3) 4.1 (2) 12.2 (6) 42.4 (14) 32.7 (16)
Liquorice 40.9 (18) 59.1 (26) 0 (0) 0 (0) 36.4 (16) 0 (0)
Oats 10.3 (8) 28.2 (22) 7.7 (6) 10.3 (8) 32.3 (20) 43.6 (34)
Passionflower 23.5 (12) 3.9 (2) 19.6 (10) 7.8 (4) 71.4 (20) 45.1 (23)
Rhodiola 8.1 (3) 5.4 (2) 16.2 (6) 2.7 (1) 75 (9) 67.6 (25)
Skullcap 9.4 (3) 3.1 (1) 3.1 (1) 6.3 (2) 62.5 (5) 78.1 (25)
St John’s wort 6 (6) 1 (1) 61 (61) 9 (9) 33.8 (26) 23 (23)
Valerian 4.8 (5) 1 (1) 70.5 (74) 2.9 (3) 33.7 (28) 21 (22)
Withania 14.3 (5) 8.6 (3) 5.7 (2) 0 (0) 60 (6) 71.4 (25)
Zizyphus 3.2 (1) 0 (0) 9.7(3) 3.2 (1) 66.7 (4) 83.9 (26)
Other 14.4 (15) 0 (0) 19.2 (20) 6.7 (7) 17.7 (14) 59.6 (62)
aReported as percentage of users of each herb in previous 12 months
Table 6 Frequency of use of herbal medicine information
sources
Information sources Frequency of use
% (n)a
The Internet 53 (212)
Friend or family 43.8 (175)
Health food shop assistant 24.8 (99)
Herbal medicine practitioner 21.8 (87)
General practitioner 21.5 (86)
Magazines/newspapers 17.5 (70)
Pharmacist 17.3 (69)
Pharmacy assistant 13.8 (55)
Other health care provider 9.5 (38)
Other 9.5 (38)
Media advertising 5.5 (22)
aMultiple response item reported as percent of cases
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were significantly more likely to use herbal medicines
for anxiety symptoms in the previous 12 months than
those without anxiety symptoms (M = 3.99, SE = 0.28,
95 % CI [3.44, 4.55]). Anxiety symptoms in the previous
12 months accounted for 2 % of the variability of herbal
medicine use in the previous 12 months, which is a
small effect size, partial η2 .02. See Table 8 for results of
the two-way ANOVA. There was no interaction between
anxiety disorder diagnosis and anxiety symptoms in the
previous 12 months.
Simple logistic regression showed that severity of anx-
iety symptoms in the previous week statistically signifi-
cantly predicted 6 % (Nagelkerke R2) of the variance in
current herbal medicine use for anxiety symptoms, χ2 =
18.03, and correctly classified 63.5 % of cases. The re-
sults and odds ratio are presented in Table 9, which sug-
gest that the odds of currently using herbal medicines
for anxiety symptoms are significantly greater for people
with more severe anxiety symptoms.
Discussion
This is the first known study to provide a comprehensive
description of how Australian adults who experience anx-
iety symptoms are using herbal medicines. Almost half the
participants had previously been diagnosed with an
anxiety disorder, with the remaining having experienced
anxiety symptoms. The majority (73 %) used herbal medi-
cines specifically for their anxiety symptoms, with half the
cohort having experienced moderate to severe anxiety
symptoms in the previous week. These results support
previous research finding that Australian adults are using
herbal medicines for anxiety symptoms [23].
Participants had consultations with a range of health
professionals. Medical doctors were the most frequently
consulted health practitioners in the previous 12 months,
but they did not prescribe herbal medicines often. This
contrasted with Western herbalists who were one of the
Table 7 Disclosure of herbal medicine use to doctor and other health practitioners
Disclosure of herbal medicine use to doctor (N = 400, df = 1) Disclosure of herbal medicine use to other health practitioners (N = 400,
df = 1)
No % (n) Yes % (n) Total % (n) Chi square p Cramer’s V No % (n) Yes % (n) Total % (n) Chi square p Cramer’s V
Anxiety disorder diagnosis
Yes 43.8 (91) 56.3 (117) 47 (188) 46.3 (87) 53.7 (101) 47 (188)
No 63 (121) 37 (71) 53 (212) 63.2 (134) 36.8 (78) 53 (212)
Total 48 (192) 52 (208) 100 (400) 14.88** .000 .19 55.3 (221) 44.8 (179) 100 (400) 11.55** .001 .17
Anxiety symptoms in previous 12 months
Yes 15.9 (33) 84.1 (175) 82.3 (329) 54.1 (178) 45.9 (151) 82.3 (329)
No 19.8 (38) 80.2 (154) 17.8 (71) 60.6 (43) 39.4 (28) 17.8 (71)
Total 48 (192) 52 (208) 100 (400) 1.05 .305 55.3 (221) 44.8 (179) 100 (400) .99 .321
Used herbal medicines for anxiety symptoms
Yes 20.7 (43) 79.3 (165) 72.8 (291) 48.5 (141) 51.5 (150) 72.8 (291)
No 34.4 (66) 65.6 (126) 27.3 (109) 73.4 (80) 26.6 (29) 27.3 (109)
Total 48 (192) 52 (208) 100 (400) 9.46** .002 .15 55.3 (221) 44.8 (179) 100 (400) 19.96** .000 .22
Used pharmaceuticals for anxiety symptoms
Yes 35.1 (73) 64.9 (135) 55.3 (221) 48.4 (107) 51.6 (114) 55.3 (221)
No 52.5 (106) 44.8 (86) 44.8 (179) 63.7 (114) 36.3 (65) 44.8 (179)
Total 48 (192) 52 (208) 100 (400) 16.33** .000 .20 55.3 (221) 44.8 (179) 100 (400) 9.39** .002 .15
Combined pharmaceuticals with herbal medicines for anxiety symptoms
Yes 66.8 (139) 33.2 (69) 27.5 (110) 40.9 (45) 59.1 (65) 27.5 (110)
No 78.6 (151) 21.5 (41) 72.5 (290) 60.7 (176) 39.3 (114) 72.5 (290)
Total 48 (192) 52 (208) 100 (400) 6.70** .008 .13 55.3 (221) 44.8 (179) 100 (400) 12.62** .000 .18
** < p = 0.01
Note. Chi-square test of contingency tested relations between dichotomous variables
Table 8 Anxiety disorder diagnosis and anxiety symptoms in
previous 12 months predicting herbal medicine use
Variables df F SS p
Anxiety disorder diagnosis 1, 396 7.77 36.78 .006**
Anxiety symptoms in previous 12 months 1, 396 9.66 45.75 .002**
AD x AS 1, 396 2.54 12.05 .112
** < p = 0.01
Note. AD anxiety disorder diagnosis, AS anxiety symptoms. A two-way analysis
of variance (ANOVA) examined the effects of anxiety disorder diagnosis and
having anxiety symptoms in previous 12 months on herbal medicine use in
the previous 12 months
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least consulted practitioners, who prescribed herbal
medicines most frequently. The low frequency of consul-
tations with Western herbalists is consistent with previ-
ous research including Australian woman [24]. Western
herbalists are unregulated in Australia and not consid-
ered part of the conventional health system [13], which
may partly explain why so few people reported consult-
ing these practitioners. However, in the current study
consultations to naturopaths (who are also unregulated)
were reported to be as frequent as TCM practitioners
who are regulated, suggesting other factors are involved.
Some practitioners specialise in Western herbal medi-
cine, but advertise themselves as other types of practi-
tioners; for example, many naturopaths specialise in
Western herbal medicine. This may cause confusion for
health care consumers in terms of being able to accur-
ately identify what type of practitioner they are consult-
ing, which may have affected the accuracy of the
reporting of these consults. Despite the low number of
participants consulting Western herbalists they were re-
ported to have the second highest number visits in the
previous 12 months for a practitioner. It is unclear why
this is the case.
Practitioners with specialised training in the clinical
prescription of herbal medicines (i.e. Western herbalists,
TCM practitioners, and naturopaths) were reported to
prescribe herbal medicines more frequently than other
practitioners (e.g. medical doctors and psychologists).
This is unsurprising given that other health practitioners
do not receive undergraduate training in herbal medi-
cine prescribing; therefore, may either lack confidence
or ability to prescribe these medicines, be unaware of
the efficacy and safety of herbal medicines, or choose
other treatments that they consider more appropriate,
such as pharmaceuticals and psychological interventions.
A range of herbal medicines were being used to treat
anxiety symptoms, with variation in the preparation
types used for each herb. This is likely to relate to fac-
tors such as taste, availability of the type of preparation,
who is prescribing or selling the herbal medicine, and
cultural use. For example, chamomile was the most fre-
quently used herbal medicine for anxiety symptoms, the
most frequently self-prescribed, and most frequently
consumed as a tea. The high rates of self-prescription of
chamomile is likely to reflect this herb being widely
available, and commonly being consumed as a beverage
for enjoyment. In contrast, valerian and St John’s wort
were also frequently self-prescribed, however they are
more commonly available as a tablet, which was the
preparation most frequently used for these herbs.
High amounts of self-prescribing of herbal medicines
was found in this cohort (up to 68 %), which is consistent
with self-prescribing previously reported in the Australian
general population (51.8 %) [23], and more recently in
women during pregnancy (77.9 %) [15]. In contrast, there
was less practitioner prescribing reported, with only up to
31.3 % of individual herbs being prescribed by herbal
medicine practitioners, which is slightly higher than previ-
ously reported in the general Australian population (27.4 %)
[23]. People with anxiety disorders have been found to
have barriers to accessing health care, such as lack of time,
treatment cost, embarrassment, and stigma [25], which
may partly explain the high rates of self-prescribing of
herbal medicines in our study. In addition, people with
mental health problems have reported preference to self-
manage their symptoms [26]. We also found that 48 % of
participants did not disclose their herbal medicine use to
their treating medical doctor. This is consistent with re-
search in psychiatric outpatients finding that between 37
[16] and 49 % [27] of patients did not disclose their CAM
use to their healthcare providers. In addition, our study
found that those using herbal medicines concurrently with
pharmaceuticals were less likely to disclose their use. Over
27 % of participants had used herbal medicines concur-
rently with pharmaceuticals for their anxiety symptoms,
which is consistent with CAM users in an Australian
population sample (26 %) [23]. However, in our study the
people who had an anxiety disorder diagnosis, or used
pharmaceutical medicines for anxiety symptoms were
more likely to disclose their herbal medicine use to their
medical doctor. It is difficult to identify why these people
are more likely to disclose herbal medicine use as it contra-
dicts findings from research mentioned previously. Perhaps
they are more comfortable with discussing their anxiety
and other issues with their health practitioners as they have
already been prescribed a medication for their anxiety
symptoms and may not be concerned about the stigma, or
they have an established rapport with their health care pro-
viders and feel supported to disclose their use.
Self-prescription and non-disclosure of herbal medi-
cine use is problematic as it does not allow for health
practitioners to provide their patients with optimal care,
and there is the potential for herb-drugs interactions.
For example, kava (Piper methysticum), gingko (Gingko
biloba), St John’s wort (Hypericum perforatum) and gin-
seng (Panax ginseng)—all used by participants in our
study—have been found to interact with various classes
of commonly prescribed pharmaceuticals [12]. The rea-
sons for these behaviours are unclear, however it may be
that those who are combining herbal medicines with
pharmaceuticals are concerned about disclosing this to
Table 9 Logistic regression predicting likelihood of current
herbal medicine use for anxiety symptoms
Variable B SE Wald df p Odds
Ratio




.09 .02 16.20 1 .00 1.10 [1.05, 1.15]
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their health care providers for fear of discrimination.
Discrimination in health care was found to be related to
self-prescribed herbal medicine use in a representative
sample of US adults [28]. In addition, being dissatisfied
with the medical encounter has been found to predict
CAM use in both cancer [29, 30] and general population
samples [31, 32]. More research is needed in this area to
determine the reasons for discrimination by health practi-
tioners, especially considering that people with mental
health problems report stigma as a barrier to health care [5].
Herbs with evidence of efficacy in treating anxiety (i.e.
kava and passionflower) [33] were not frequently used in
this study, suggesting that people may not receive infor-
mation about the efficacy of these herbal medicines. This
is consistent with a US study finding that people were
not using herbal medicines according to their evidence-
based indications [14]. This may be related to our find-
ing that non-professional information sources, such as
the Internet and family and friends, were the most fre-
quently used when making decisions about herbal medi-
cine use. High use of non-professional information
sources has previously been found in psychiatric patients
[16] and other at risk cohorts, such as pregnant women
[15]. It is not clear why people use non-professional in-
formation sources. However, qualitative interviews found
that people with anxiety value their own experience and
that of important others as a form of evidence [34]. This
is an important behaviour to understand, and needs
more research.
Almost half the participants were currently taking
herbal medicines for anxiety symptoms while not experi-
encing problematic anxiety symptoms in the previous
week. It is unclear why they were taking these medicines.
However, herbal medicines could be effective in provid-
ing some relief of anxiety symptoms, or are being taken
as a preventative treatment. Maintaining health and
preventing illness [16] have previously been identified as
reasons for taking herbal medicines. Zhang and col-
leagues [23] reported that over 50 % of Australian adults
who took commonly used herbs did so to enhance their
health. The use of herbal anxiolytics when experiencing
less severe anxiety may potentially prevent subthreshold
anxiety from developing into a more serious disorder.
This is an area for future research.
We found that people with an anxiety disorder diagno-
sis were more likely to use herbal medicines than those
without. This is consistent with previous research
reporting higher amounts of herbal medicine use in
people with an anxiety disorder diagnosis [8]. We also
found that people with more severe anxiety symptoms in
the previous week were more likely to use herbal medi-
cines for anxiety symptoms compared to those without,
which suggests that anxiety severity increases the use of
herbal medicines for anxiety symptoms. As over 30 % of
people with anxiety disorders do not respond to evidence-
based psychological and pharmaceutical treatments [4],
they may seek additional relief for anxiety symptoms,
which could be one reason why people are taking herbal
medicines concurrently with pharmaceuticals. Some people
may also be using psychological treatments at the same
time as taking herbal medicines. Participants were not
asked about their use of psychological therapies in this
study. Future research could seek to determine the full
range of treatments people are using for their anxiety
symptoms and reasons for choosing these therapies.
In respect to study limitations, this study relied on
self-report of previous herbal medicine use and anxiety
disorder diagnosis, which may be affected by recall bias.
As a convenience sample was used the generalisability of
the results is limited due to potential response bias. In
addition, the prevalence of herbal medicine use for anx-
iety symptoms in this cohort cannot be generalised to
the broader population. However, the sample demo-
graphics suggest that the sample was reasonably repre-
sentative of the Australian population with regards to
gender [35], and geographic location [36], but slightly
older than the median population age [35]. This study
does provide a comprehensive description of herbal
medicine use behaviour in a sample of adults who ex-
perience anxiety. More research on specific population
samples is needed to determine prevalence rates of
herbal medicine use for anxiety.
Future research should seek to understand decision
making involved in using herbal medicines for anxiety
symptoms. In certain instances self-prescription can be
done safely; however, it can be difficult for the public to
assess the information presented to them [37]. In
addition, it is difficult to determine if people are receiv-
ing the most suitable treatment for their needs, as they
are self-prescribing, consulting with a range of health
practitioners, and not disclosing their herbal medicine
use. Therefore, it needs to be determined how accurate
reliable information can be made more accessible to
both the public and health practitioners, so they can be
better educated about the efficacy, effectiveness, and
safety of herbal anxiolytics to ensure the most suitable
treatments are used. As medical doctors were the most
frequently seen health care provider in our study it is
critical that they continue to educate themselves and
their patients about herbal medicine.
Conclusions
This study is the first to measure how a cohort of
Australian adults with an experience of anxiety are using
herbal medicines. Herbal medicines are being used by
adults with anxiety and are commonly self-prescribed
for anxiety symptoms. Health practitioners who are ex-
perts in herbal medicine prescribing are consulted
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infrequently. In addition, herbal medicine use is often
not disclosed to health practitioners. These behaviours
are concerning as people may not be receiving the most
suitable treatments for their needs, and may even be
dangerous. These findings can inform future research to
assist in determining the reasons for non-disclosure, and
high rates of self-prescribing. Given that herbal medicine
use and self-prescription in the general population is in-
creasing, it is critical we develop a better understanding
of why people are using these medicines, and how we
can develop improved health literacy to help with treat-
ment decision making to ensure they receive optimal
care.
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